Editor's Choice
M-A | Nonpharmacological interventions to lengthen sleep duration in healthy children.
19 Sep, 2022 | 12:44h | UTCNonpharmacological Interventions to Lengthen Sleep Duration in Healthy Children: A Systematic Review and Meta-analysis – JAMA Pediatrics (free for a limited period)
Editorial: Children’s Sleep and Our Power to Improve It – JAMA Pediatrics (free for a limited period)
Commentary: Data Demonstrates the Best Intervention for Pediatric Sleep Health is Earlier Bedtime – HCP Live
Commentary on Twitter
Supporting children to go to bed earlier can increase sleep duration in healthy children, and interventions to encourage earlier bedtimes should be included. https://t.co/i8BzSKwlQX #Research
— JAMA Pediatrics (@JAMAPediatrics) September 14, 2022
The Lancet Commission on lessons for the future from the COVID-19 pandemic – “a massive global failure.”
16 Sep, 2022 | 13:03h | UTCHomepage: The Lancet COVID-19 Commission
The Lancet Commission on lessons for the future from the COVID-19 pandemic
Editorial: COVID-19: the case for prosociality
Infographic: COVID-19 response: a massive global failure
Commentaries:
WHO responds to The Lancet COVID-19 Commission – World Health Organization
Covid-19: Commission describes “massive global failures” of pandemic response – The BMJ
Lancet Commission on COVID-19 response: ‘Massive global failure’ – CIDRAP
Guideline Synopsis | AHA/ACC Guideline for the management of heart failure.
16 Sep, 2022 | 13:01h | UTCManagement of Heart Failure – JAMA (free for a limited period)
Original Article: #ACC22 – 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.
The Lancet Commission | Towards the elimination of chronic obstructive pulmonary disease.
16 Sep, 2022 | 13:02h | UTCHomepage: Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission – The Lancet
Commission: Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Editorial: COPD: from an end-stage disease to lifelong lung health
Invited Commentary: Classification of COPD: fostering prevention and precision medicine in the Lancet Commission on COPD
Commentary: Proposed classification of COPD according to major risk factors – News Medical
AHA Scientific Statement | Management of patients at risk for and with left ventricular thrombus.
16 Sep, 2022 | 13:00h | UTC
RCT | Among neonates with probable bacterial infection, switching from intravenous to oral antibiotics (amoxicillin–clavulanic acid) was noninferior to a full course of intravenous antibiotics and resulted in shorter hospitalization (median duration of 3.4 vs. 6.8 days).
16 Sep, 2022 | 12:59h | UTCEfficacy and safety of switching from intravenous to oral antibiotics (amoxicillin–clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial – The Lancet Child & Adolescent Health (link to abstract – $ for full-text)
Commentary: Dutch team devise less painful ‘drip and drink’ antibiotics treatment for babies – Dutch News
Commentaries on Twitter
*New trial*—early switch to #OralAntibiotics is not inferior to full-course IV antibiotics in #neonates with probable bacterial infection; & adverse events were not increased with use of oral antibiotics
By @IKMReiss @karelallegaert & colleagues
https://t.co/2yzeh3ptuc pic.twitter.com/BgBosxfECC
— The Lancet Child & Adolescent Health (@LancetChildAdol) September 12, 2022
In term and near-term infants <28 days with probable bacterial infection, how safe is it to switch to oral Amox-Clav as opposed to completing a course of intravenous antibiotics? A new RCT in @Lancet tries to answer this question.https://t.co/M2Za54cfxF#EBNeoAlerts#NeoEBM pic.twitter.com/zKpIiW1Whx
— Evidence-Based Neo (@EBNEO) September 12, 2022
(Thread – click for more)
Efficacy & safety of switching from intravenous to oral antibiotics (amoxicillin–clavulanic acid) vs full course of IV antibiotics in neonates with probable bacterial infection (RAIN):multicentre, randomised,open-label,non-inferiority trial -The Lancet https://t.co/mcyr9bILRq
— Prof. Dr. Sanjeev Bagai (@BagaiDr) September 13, 2022
Study | The specificity and positive predictive value of high-sensitivity cardiac troponin I for the diagnosis of myocardial infarction are reduced in older individuals.
16 Sep, 2022 | 12:57h | UTCInfluence of Age on the Diagnosis of Myocardial Infarction – Circulation
RCT | Short-term outcomes of laparoscopy-assisted vs. open surgery for patients with low rectal cancer.
16 Sep, 2022 | 12:58h | UTC
Commentary on Twitter
https://twitter.com/JAMAOnc/status/1570532915393744896
RCT | In patients with acute pancreatitis, early aggressive hydration resulted in a higher incidence of fluid overload without improvement in clinical outcomes.
15 Sep, 2022 | 13:15h | UTCAggressive or Moderate Fluid Resuscitation in Acute Pancreatitis – New England Journal of Medicine (link to abstract – $ for full-text)
RCT | Effects of cocoa extract and a multivitamin on cognitive function.
15 Sep, 2022 | 13:14h | UTC
Cohort Study | Patients diagnosed with diabetes by oral glucose tolerance test without elevated HbA1c had similar cardiovascular and renal disease risks as those without diabetes.
15 Sep, 2022 | 13:12h | UTC
Commentary on Twitter
#OriginalResearch: Oral glucose tolerance test diagnosed #diabetes were not confirmed by HbA1c during 4 year follow-up. Cases without HbA1c confirmation had similar vascular risk as the diabetes-free population. @whitehall2study @MikaKivimaki #AHAJournals https://t.co/ujC8cjRS7S pic.twitter.com/CRR3zlm5x2
— Circulation (@CircAHA) August 30, 2022
New research estimates the overall disease burden of genetic risk factors.
15 Sep, 2022 | 13:13h | UTCNews Release: New research estimates the overall disease burden of genetic risk factors – University of Helsinki
Original Study: Genetic risk factors have a substantial impact on healthy life years – Nature Medicine
Commentaries on Twitter
From combining genetic data in over 730,000 people and 80 diseases burden estimates:
"Genetic risk factors can explain a sizable number of healthy life years lost both at the individual and population level"https://t.co/ggljmkcmHG @NatureMed @andganna @DrSakari @FIMM_UH pic.twitter.com/rUI1Ua3mIP— Eric Topol (@EricTopol) September 12, 2022
An analysis in @NatureMedicine estimates that genetic risk factors significantly impact the number of healthy life years lost both at the individual and population level. https://t.co/I2mNNOrtYi pic.twitter.com/1WfI6fXbZ8
— Nature Portfolio (@NaturePortfolio) September 12, 2022
RCT | Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis/cruris.
15 Sep, 2022 | 13:10h | UTCEffect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial – JAMA Dermatology (free for a limited period)
Commentary on Twitter
Itraconazole is highly efficacious at all 3 doses but requires prolonged treatment, and a substantial number of patients relapsed after successful treatment. https://t.co/oOMkvp1WIp #Research pic.twitter.com/PoNYu50Cxr
— JAMA Dermatology (@JAMADerm) September 14, 2022
Cohort Study | Long-term outcomes among men undergoing active surveillance for prostate cancer.
15 Sep, 2022 | 13:11h | UTCInvited Commentary: Exploring the Long-term Outcomes of Active Surveillance Among Men With Prostate Cancer—Best for Whom? – JAMA Network Open
RCT | Robotic vs. laparoscopic surgery for middle and low rectal cancer.
15 Sep, 2022 | 13:09h | UTCRobotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentaries:
Robotic Surgery Tops Laparoscopic Surgery for Middle and Low Rectal Cancer — Randomized trial shows fewer positive circumferential resection margins with robotic technique – MedPage Today (free registration required)
Commentaries on Twitter
RCT: Robot versus laparoscopic surgery for middle and low rectal cancer – 11 hospitals, 1171 patients
🤖 vs lap:
CRM+ 4% vs 7%
Complications 16% vs 23%
APR 17% vs 23%
Conversion 2% vs 4%https://t.co/3mU9m7sDVB#colorectalcancer #colorectalsurgery— Ville Sallinen (@villesallinen) September 8, 2022
New research online – Feng et al – Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trialhttps://t.co/B60DV5e4iJ#GITwitter @OncoAlert #rectalcancer #crcsm #SoMe4Surgery pic.twitter.com/9NoXXyCGwM
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) September 8, 2022
M-A | Role of pessaries in the treatment of pelvic organ prolapse.
15 Sep, 2022 | 13:08h | UTCRole of Pessaries in the Treatment of Pelvic Organ Prolapse: A Systematic Review and Meta-analysis – Obstetrics & Gynecology (free for a limited period)
USPSTF Statement | The current evidence is insufficient to recommend routine screening for prediabetes and type 2 diabetes in children and adolescents.
14 Sep, 2022 | 13:23h | UTCEditorials:
Recommendations for Screening Children and Adolescents for Prediabetes and Type 2 Diabetes – JAMA
Broader Screening for Youth-Onset Type 2 Diabetes—We Just Are Not There Yet – JAMA Network Open
Patient Page: Screening for Type 2 Diabetes in Children and Adolescents – JAMA
Author Interview: USPSTF Recommendation: Screening for Prediabetes and Diabetes in Children and Adolescents – JAMA
Study | Vitamin D3 and omega-3 fatty acids not helpful in reducing the risk of frailty.
14 Sep, 2022 | 13:20h | UTCNews Release: Vitamin D3 and omega-3 fatty acids not helpful in reducing risk of frailty – Brigham and Women’s Hospital
Invited Commentary: There Is No Magic Pill to Prevent Frailty—You Still Have to Eat Your Vegetables – JAMA Network Open
Commentary on Twitter
New findings from the VITAL trial do not support the routine use of vitamin D3 or omega-3 fatty acid supplementation in community-dwelling older adults for the prevention of frailty. #OAResearch https://t.co/LIJO8bJ0Wk #OAResearch
— JAMA Network Open (@JAMANetworkOpen) September 13, 2022
Cohort Study | Risk factors for heart disease and stroke are largely similar in men and women globally.
14 Sep, 2022 | 13:18h | UTCNews Release: Risk factors for heart disease and stroke are largely similar in men and women globally, finds study – McMaster University
Original Study: Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
https://twitter.com/TheLancet/status/1569636002762817536
RCT | Extended duration thromboprophylaxis (continued for 56 days postoperatively) is not beneficial after surgical resection of colorectal cancer.
14 Sep, 2022 | 13:22h | UTC
Cohort Study | Prospective associations of daily step counts and intensity with cancer and cardiovascular disease incidence and mortality and all-cause mortality.
14 Sep, 2022 | 13:17h | UTCCommentaries:
Higher Step Counts Equal Better CV Health: UK Biobank – TCTMD
Pace as important as 10,000 steps for health, finds new research – University of Sidney
How Many Steps a Day (and How Fast) to Lengthen Your Life? – HealthDay
M-A of randomized trials | In patients hospitalized with community-acquired pneumonia, corticosteroids reduce the need for mechanical ventilation without significant effects on mortality, treatment failure, or adverse events.
14 Sep, 2022 | 13:16h | UTCEffect of corticosteroids on mortality and clinical cure in community-acquired pneumonia: A systematic review, meta-analysis, and meta-regression of randomized control trials – CHEST Journal (link to abstract – $ for full-text)
Perspective | Redefining critical illness.
14 Sep, 2022 | 13:13h | UTCRedefining critical illness – Nature Medicine
Review | Multisystem inflammatory syndrome in children (MIS-C) and neonates (MIS-N) associated with COVID-19: optimizing definition and management.
14 Sep, 2022 | 13:15h | UTC
Commentary on Twitter
Proposed classification of Multisystem inflammatory syndrome in #neonates (MIS-N)
Clinical features
Treatment and immunological mechanisms#MISC #covid19 #PIMSTS #PedsICU#NeoEBM @DrSBagci #NeoTwitter #Neonatology @DrKenRemy1 @ChrisCarrollMD @lizWWyld https://t.co/tDuM51GMr4 pic.twitter.com/PNobOOzevX— Yonca Bulut M.D. (@yoncabulutmd) September 6, 2022
Under a http://creativecommons.org/licenses/by/4.0/ License
RCT | Dexamethasone is not effective for the treatment of dyspnea in patients with cancer and increases the risk of adverse events.
13 Sep, 2022 | 13:22h | UTCEffect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial – The Lancet Oncology (free for a limited period)
Commentary on Twitter
Our phase III randomized study, published in Lancet Oncology today, showed high-dose steroid didn’t improve SOB and should not be used routinely in pts with lung ca for SOB palliation. My personal link in Lancet Oncology article ⁰https://t.co/Mj0AAzMujB pic.twitter.com/FMG7csHZsn
— Joe Y Chang (@JoeChangMD) September 7, 2022


